Monday, October 20, 2008

Obesity Likely Contributing To Older, Minority Women's Increased Arthritis Risk

Older minority women are more likely than their white counterparts to develop osteoarthritis, the most common form of arthritis, likely because of risk factors such as obesity, according to a study published last month in the Journal of American Geriatrics Society, Reuters Health reports.

read more

Read more ...

With Halloween approaching, the American Optometric Association (AOA) is warning consumers about the risks of wearing decorative contact lenses without a prescription from an eye doctor. These non-corrective lenses, which are designed only to change the appearance of the eyes, are easily accessible to consumers and are especially popular around Halloween.

read more

Read more ...

Bio-Detek's PocketCPR device will be used in a statewide campaign to teach Arizona 6th through 12th graders how to correctly perform continuous chest compression CPR in the event of a sudden cardiac arrest (SCA). The goal of this Arizona initiative is to teach this technique to children so they can perform it properly and train family members.

read more

Read more ...

The number of new HIV cases recorded among men who have sex with men in Hong Kong has increased every year since 2003, and up to one-third of the population could be HIV-positive by 2020 if prevention programs are not effective, researchers said recently, Reuters reports. The number of newly recorded annual HIV cases among MSM increased from 50 in 2003 to 67 in 2004, 96 in 2005 and 112 in 2006. The number of newly recorded annual HIV cases among heterosexuals stayed within the range of 110 to 116 each year, according to Reuters.

read more

Read more ...

Some New York state health care workers -- including emergency department workers, paramedics and EMTs -- are hoping to change a state law that requires written consent prior to HIV testing of patients in the event that health workers experience needle-stick injuries, the Albany Times Union reports.

read more

Read more ...

The Sacramento Bee on Friday examined the effect of HIV/AIDS on Hispanics nationwide and a concern among some public health officials that the disease could be affecting the population more than believed because of a lag in testing. According to the Bee, Hispanics constituted about 20% of new AIDS cases in 2006 even though they make up 14% of the U.S. population.

read more

Read more ...

Sunday, October 19, 2008

Kidney Cancer - Causes, Symptoms, Risks Factors and More

Kidney cancer or renal carcinoma usually occurs in older people and accounts for about 2 to 3% of cancers in adults, affecting about twice as many men as women. In adults, the most common type of kidney tumor is renal cell carcinoma, which begins in the cells that line the small tubes within your kidneys. Kidney cancer rarely strikes children and young adults; the exceptions are a pediatric kidney cancer called Wilms tumor and some forms of hereditary kidney cancer syndromes, such as von Hippel-Lindau disease.

Start Of Phase 2 Study Of ACE-011 In Patients With Multiple Myeloma

Celgene Corporation (NASDAQ:CELG) and Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, today announced the initiation of a Phase 2 clinical study of its lead compound ACE-011 in patients with multiple myeloma. ACE-011 is being developed to treat bone loss associated with multiple myeloma and other cancers. Complete news at...

Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, and Specialised Therapeutics Australia Pty Ltd, today announced that approval has been received from the Therapeutic Goods Administration (TGA) in Australia to market ABRAXANE® (nanoparticle albumin-bound paclitaxel) 100 mg powder for injection (suspension) for the treatment of metastatic carcinoma of the breast after failure of anthracycline therapy. Complete news at...

Ardea Biosciences, Inc. (Nasdaq:RDEA) announced today that it has initiated a Phase 1/2 study of RDEA119, its lead mitogen-activated ERK kinase (MEK) inhibitor for the treatment of cancer, in combination with Nexavar, which is currently approved for the treatment of unresectable hepatocellular carcinoma and advanced renal cell carcinoma. Complete news at...